These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15606417)

  • 21. Stratified analysis in randomized trials with noncompliance.
    Matsui S
    Biometrics; 2005 Sep; 61(3):816-23. PubMed ID: 16135033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating effects from randomized trials with discontinuations: the need for intent-to-treat design and G-estimation.
    Greenland S; Lanes S; Jara M
    Clin Trials; 2008; 5(1):5-13. PubMed ID: 18283074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of recurrent events: application to a clinical trial of colony stimulating factor with the endpoint of febrile neutropenia.
    Matsui S; Ohashi Y
    Stat Med; 1999 Sep 15-30; 18(17-18):2409-20. PubMed ID: 10474149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Estimation of treatment effect adjusting for treatment changes using the intensity score method: application to a large primary prevention study for coronary events (MEGA study).
    Tanaka Y; Matsuyama Y; Ohashi Y;
    Stat Med; 2008 May; 27(10):1718-33. PubMed ID: 17922525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal and repeated cross-sectional cluster-randomization designs using mixed effects regression for binary outcomes: bias and coverage of frequentist and Bayesian methods.
    Localio AR; Berlin JA; Have TR
    Stat Med; 2006 Aug; 25(16):2720-36. PubMed ID: 16345043
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The power of the Mantel-Haenszel test for grouped failure time data.
    Wallenstein S; Wittes J
    Biometrics; 1993 Dec; 49(4):1077-87. PubMed ID: 8117902
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Likelihood methods for treatment noncompliance and subsequent nonresponse in randomized trials.
    O'Malley AJ; Normand SL
    Biometrics; 2005 Jun; 61(2):325-34. PubMed ID: 16011678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blinded assessment of treatment effects utilizing information about the randomization block length.
    Miller F; Friede T; Kieser M
    Stat Med; 2009 May; 28(12):1690-706. PubMed ID: 19340815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predicting event times in clinical trials when randomization is masked and blocked.
    Donovan JM; Elliott MR; Heitjan DF
    Clin Trials; 2007; 4(5):481-90. PubMed ID: 17942464
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correcting for non-compliance of repeated binary outcomes in randomized clinical trials: randomized analysis approach.
    Matsuyama Y
    Stat Med; 2002 Mar; 21(5):675-87. PubMed ID: 11870809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of multivariate recurrent event data with time-dependent covariates and informative censoring.
    Zhao X; Liu L; Liu Y; Xu W
    Biom J; 2012 Sep; 54(5):585-99. PubMed ID: 22886587
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Joint frailty models for recurring events and death using maximum penalized likelihood estimation: application on cancer events.
    Rondeau V; Mathoulin-Pelissier S; Jacqmin-Gadda H; Brouste V; Soubeyran P
    Biostatistics; 2007 Oct; 8(4):708-21. PubMed ID: 17267392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discussion of "Identifiability and estimation of causal effects in randomized trials with noncompliance and completely nonignorable missing data".
    Small DS; Cheng J
    Biometrics; 2009 Sep; 65(3):682-6; discussion 689-91. PubMed ID: 18759846
    [No Abstract]   [Full Text] [Related]  

  • 35. Bayesian statistical inference enhances the interpretation of contemporary randomized controlled trials.
    Wijeysundera DN; Austin PC; Hux JE; Beattie WS; Laupacis A
    J Clin Epidemiol; 2009 Jan; 62(1):13-21.e5. PubMed ID: 18947971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of the principal stratification approach to the Faenza randomized experiment on breast self-examination.
    Mattei A; Mealli F
    Biometrics; 2007 Jun; 63(2):437-46. PubMed ID: 17688496
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bootstrap analysis of multivariate failure time data.
    Monaco J; Cai J; Grizzle J
    Stat Med; 2005 Nov; 24(22):3387-400. PubMed ID: 16237657
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating survival and association in a semicompeting risks model.
    Lakhal L; Rivest LP; Abdous B
    Biometrics; 2008 Mar; 64(1):180-8. PubMed ID: 17645782
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Noncompliance in cancer screening trials.
    Gareen IF
    Clin Trials; 2007; 4(4):341-9. PubMed ID: 17848495
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regression analysis for recurrent events data under dependent censoring.
    Hsieh JJ; Ding AA; Wang W
    Biometrics; 2011 Sep; 67(3):719-29. PubMed ID: 21039394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.